Latest market price
38.75
-0.44-1.12%
Earnings
Down 1.1% — Reported earnings — EPS beat by 15%, revenue beat by 5%.
High confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | 21.53 | EPS (ttm) | 1.80 | Insider Own | 7.92% | Shs Outstand | 115.91M | Perf Week | -0.59% |
| Market Cap | 4.49B | Forward P/E | 14.16 | EPS next Y | 2.74 | Insider Trans | 0.00% | Shs Float | 103.59M | Perf Month | 7.49% |
| Enterprise Value | 5.71B | PEG | 2.58 | EPS next Q | 0.97 | Short Float | 7.33% | Perf Quarter | 1.79% | ||
| Income | 216.00M | P/S | 1.34 | EPS this Y | 150.50% | Short Ratio | 3.35 | Perf Half Y | 42.15% | ||
| Sales | 3.36B | P/B | 2.17 | EPS next Y | 3.89% | ROA | 3.36% | Short Interest | 7.59M | Perf YTD | 66.74% |
| Book/sh | 17.84 | P/C | 8.91 | EPS next 5Y | 8.35% | ROE | 26.76% | 52W High | 40.53 -4.39% | Perf Year | 48.07% |
| Cash/sh | 4.35 | P/FCF | 14.30 | EPS past 3/5Y | — | ROIC | 13.12% | 52W Low | 21.60 79.40% | Perf 3Y | 148.40% |
| Dividend Est. | 0.36 (0.93%) | EV/EBITDA | 9.39 | Sales past 3/5Y | 8.26% 35.34% | Gross Margin | 29.98% | Volatility | 2.64% 2.89% | Perf 5Y | 91.93% |
| Dividend TTM | 0.36 (0.93%) | EV/Sales | 1.70 | EPS Y/Y TTM | -1.64% | Oper. Margin | 13.25% | ATR (14) | 1.15 | Perf 10Y | -3.03% |
| Dividend Ex-Date | Aug 26, 2026 | Quick Ratio | 0.74 | Sales Y/Y TTM | 4.51% | Profit Margin | 6.42% | RSI (14) | 53.60 | Recom | 2.52 |
| Dividend Gr. 3/5Y | — -1.73% | Current Ratio | 0.78 | EPS Q/Q | 88.89% | SMA20 | 0.81% | Beta | 1.04 | Target Price | 39.22 |
| Payout | 18.89% | Debt/Eq | 0.83 | Sales Q/Q | 15.41% | SMA50 | 4.80% | Rel Volume | 1.43 | Prev Close | 39.19 |
| Employees | 27,900 | LT Debt/Eq | 0.83 | Earnings | Nov 03 | SMA200 | 23.48% | Avg Volume | 2.05M | Price | 38.75 |
| IPO Date | Apr 24, 2007 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 15.29% 5.00% | Net Debt/EBITDA | 2.01 | Volume | 2,927,320 | Change | -1.12% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-23-26 | Reiterated | Roth Capital | Buy | $44 → $45 |
| Aug-14-26 | Downgrade | JP Morgan | Overweight → Neutral | |
| Jul-31-26 | Reiterated | Morgan Stanley | Equal Weight | $40 → $42 |
| Jul-31-26 | Reiterated | Deutsche Bank | $34 → $40 | |
| Jul-31-26 | Reiterated | Wedbush | Outperform | $40 → $43 |
| Jul-31-26 | Reiterated | Wells Fargo | Equal Weight | $31 → $34 |
| Jul-30-26 | Reiterated | MoffettNathanson | Neutral | $35 → $40 |
| Jul-30-26 | Reiterated | Roth Capital | Buy | $38 → $40 |
| Jul-30-26 | Reiterated | Barrington | Outperform | $36 → $42 |
| Jul-29-26 | Reiterated | Morgan Stanley | Equal Weight | $36 → $40 |
Latest News· Times ET
Nov-02-26
Nov-02-2609:28AM
Oct-30-26
01:11PM
Oct-28-26
Oct-27-26
Oct-26-26
Oct-26-2601:01PM
12:20PM
Oct-22-26
Oct-22-2609:00AM
08:30AM
Cinemark to Host Third Quarter 2026 Earnings Conference Callbusinesswire.com
Oct-21-26
Oct-16-26
Oct-16-2603:06PM
Oct-15-26
Oct-14-26
Company
Cinemark Holdings, Inc., through its various subsidiaries, operates in the business of exhibiting motion pictures. As of June 30, 2022, the company managed a portfolio of 522 movie theaters, encompassing 5,868 screens located across the United States, South America, and Central America. The company was established in 1984 and maintains its principal executive offices in Plano, Texas.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,363 | 3,115 | 3,050 | 3,067 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,356 | 2,537 | 1,085 | 2,496 | — | — | — | — | — | |
| Gross Profit | 1,009 | 578 | 1,965 | 571 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 454 | 236 | 945 | 199 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 109 | 0 | 660 | 0 | — | — | — | — | — | |
| Operating Income | 446 | 342 | 359 | 372 | — | — | — | — | — | |
| Interest Expense | 142 | 164 | 166 | 173 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -41 | -24 | 60 | 23 | — | — | — | — | — | |
| Net Income Before Taxes | 263 | 154 | 253 | 221 | — | — | — | — | — | |
| Income Taxes | 43 | 12 | -60 | 30 | — | — | — | — | — | |
| Consolidated Net Income | 216 | 138 | 310 | 188 | — | — | — | — | — | |
| Net Income From Continuing Operations | 221 | 142 | 313 | 192 | — | — | — | — | — | |
| Net Income | 216 | 138 | 310 | 188 | — | — | — | — | — | |
| EPS (Recurring) | 1.86 | 1.18 | 2.54 | 1.71 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.86 | 1.18 | 2.54 | 1.71 | — | — | — | — | — | |
| EPS (Diluted) | 1.80 | 1.04 | 2.06 | 1.34 | — | — | — | — | — | |
| EBITDA | 608 | 519 | 616 | 604 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 21.53 | 22.35 | 15.04 | 10.51 | — | — | — | — | — | |
| Price To Sales Ratio | 1.33 | 0.87 | 1.22 | 0.55 | — | — | — | — | — | |
| Gross Margin | 30.00 | 18.56 | 64.43 | 18.62 | — | — | — | — | — | |
| Operating Margin | 13.26 | 10.98 | 11.77 | 12.13 | — | — | — | — | — | |
| Net Margin | 6.42 | 4.43 | 10.16 | 6.13 | — | — | — | — | — | |
| Shares Outstanding | 115 | 116 | 120 | 119 | — | — | — | — | — | |
| Market Capitalization | 4,456 | 2,696 | 3,718 | 1,677 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Zoradi Mark | Director | May 01 '26 | Sale | 29.52 | 150,000 | 4,428,000 | 286,608 | May 04 |
| Thomas Melissa | EVP, Chief Financial Officer | Feb 04 '26 | Sale | 26.05 | 7,944 | 206,941 | 159,416 | Feb 05 |
| Zoradi Mark | Director | Nov 21 '24 | Sale | 32.38 | 170,458 | 5,519,430 | 436,608 | Dec 22 |
| Zoradi Mark | Director | Dec 11 '20 | Sale | 16.17 | 2,000 | 32,340 | 121,846 | Dec 22 |
| Zoradi Mark | Director | Mar 16 '20 | Buy | 10.58 | 20,000 | 211,600 | 123,846 | Dec 22 |
| Zoradi Mark | Director | Feb 26 '20 | Buy | 25.41 | 10,000 | 254,150 | 103,846 | Dec 22 |
| Zoradi Mark | Director | Feb 25 '20 | Buy | 28.77 | 10,000 | 287,700 | 93,846 | Dec 22 |
| Zoradi Mark | Director | Sep 08 '17 | Buy | 32.19 | 5,000 | 160,950 | 13,920 | Dec 22 |
| Zoradi Mark | Director | Aug 28 '17 | Buy | 32.83 | 5,000 | 164,150 | 8,920 | Dec 22 |
| Thomas Melissa | EVP, Chief Financial Officer | Dec 10 '25 | Sale | 24.81 | 22,082 | 547,854 | 167,360 | Dec 11 |
| Thomas Melissa | EVP, Chief Financial Officer | Aug 15 '25 | Sale | 25.17 | 7,200 | 181,224 | 203,768 | Aug 18 |
| Gierhart Wanda Marie | Chief Marketing & Content Ofc | Jun 13 '25 | Sale | 31.85 | 52,524 | 1,672,889 | 94,890 | Jun 16 |
| Fernandes Valmir | Pr - Cinemark International | May 27 '25 | Sale | 33.01 | 25,000 | 825,250 | 130,612 | May 28 |
| Thomas Melissa | EVP, Chief Financial Officer | May 15 '25 | Sale | 31.43 | 7,200 | 226,296 | 210,968 | May 15 |
| Gamble Sean | Chief Executive Officer | Dec 06 '24 | Sale | 34.85 | 255,344 | 8,898,738 | 77,104 | Mar 27 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.